Long-term Efficacy and Safety of Tacrolimus Plus Ustekinumab Combination Therapy in Children With Steroid-refractory Ulcerative Colitis

被引：0

作者：

Nambu, Ryusuke ^{[1
,2
]}

Miyazawa, Ayako ^{[1
]}

Yoshida, Masashi ^{[1
]}

Hara, Tomoko ^{[1
]}

Iwama, Itaru ^{[1
]}

机构：

[1] Saitama Childrens Med Ctr, Div Gastroenterol & Hepatol, Saitama, Japan

[2] Saitama Childrens Med Ctr, Div Gastroenterol & Hepatol, 1-2 Shintoshin,Chuo Ku, Saitama 3308777, Japan

来源：

INFLAMMATORY BOWEL DISEASES | 2024年 / 30卷 / 04期

关键词：

steroid-refractory ulcerative colitis; pediatric UC; tacrolimus; ustekinumab;

D O I：

10.1093/ibd/izae013

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：686 / 687

页数：2

共 10 条

[1] Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease [J].

Christensen, Britt ;

Gibson, Peter R. ;

Micic, Dejan ;

Colman, Ruben J. ;

Goeppinger, Sarah R. ;

Kassim, Olufemi ;

Yarur, Andres ;

Weber, Christopher R. ;

Cohen, Russell D. ;

Rubin, David T. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) :486-493

[2] Tacrolimus plus ustekinumab in refractory ulcerative colitis [J].

Cortes, Irene Latras ;

Sierra-Ausin, Monica .

GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (02) :148-149

[3] The future of drug development for inflammatory bowel disease: the need to ACT (advanced combination treatment) [J].

Danese, Silvio ;

Solitano, Virginia ;

Jairath, Vipul ;

Peyrin-Biroulet, Laurent .

GUT, 2022, 71 (12) :2380-2387

[4] Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review [J].

Gisbert, Javier P. ;

Garcia, Maria Jose ;

Chaparro, Maria .

JOURNAL OF CROHNS & COLITIS, 2023, 17 (06) :972-994

[5] Combination tacrolimus and ustekinumab therapy is effective in inducing clinical, biochemical and endoscopic remission in refractory moderate to severe ulcerative colitis [J].

Gupta, Rachit ;

Schulberg, Julien D. ;

Niewiadomski, Ola ;

Wright, Emily K. .

AUTOIMMUNITY REVIEWS, 2022, 21 (07)

[6] Outcome of tacrolimus and vedolizumab after corticosteroid and anti-TNF failure in paediatric severe colitis [J].

Hamel, Blaise ;

Wu, May ;

Hamel, Elizabeth O. ;

Bass, Dorsey M. ;

Park, K. T. .

BMJ OPEN GASTROENTEROLOGY, 2018, 5 (01)

[7] Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis [J].

Sands, B. E. ;

Sandborn, W. J. ;

Panaccione, R. ;

O'Brien, C. D. ;

Zhang, H. ;

Johanns, J. ;

Adedokun, O. J. ;

Li, K. ;

Peyrin-Biroulet, L. ;

Van Assche, G. ;

Danese, S. ;

Targan, S. ;

Abreu, M. T. ;

Hisamatsu, T. ;

Szapary, P. ;

Marano, C. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13) :1201-1214

[8] A Prospective Trial with Long Term Follow-up of Patients With Severe, Steroid-Resistant Ulcerative Colitis Who Received Induction Therapy With Cyclosporine and Were Maintained With Vedolizumab [J].

Tarabar, Dino ;

El Jurdi, Katia ;

Traboulsi, Cindy ;

Yvellez, Olivia ;

Milenkovic, Zoran ;

Petrovic, Stanko ;

Subotic, Bojana ;

Gils, Ann ;

Brocic, Tanja ;

Brcerevic, Irina ;

Latinovic, Olgica ;

Jocic, Tanja ;

Rubin, David T. .

INFLAMMATORY BOWEL DISEASES, 2022, 28 (10) :1549-1554

[9]

TURNER D, 2018, J PEDIATR GASTR NUTR, V67, P257, DOI DOI 10.1097/MPG.0000000000002035

[10] Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders [J].

Wong, Emily C. L. ;

Dulai, Parambir S. ;

Marshall, John K. ;

Jairath, Vipul ;

Reinisch, Walter ;

Narula, Neeraj .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (13) :3387-+

← 1 →